Article info
Editorial
Not Such a Bright Idea: The Uk Risk-Sharing Scheme for Beta Interferon and Glatiramer Acetate in Multiple Sclerosis
Citation
Not Such a Bright Idea: The Uk Risk-Sharing Scheme for Beta Interferon and Glatiramer Acetate in Multiple Sclerosis
Publication history
- First published August 1, 2003.
Online issue publication
February 01, 2018
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2003 BMJ
Other content recommended for you
- Disease modifying therapies for relapsing multiple sclerosis
- Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis
- Drug treatment of multiple sclerosis
- UK multiple sclerosis risk-sharing scheme: a new natural history dataset and an improved Markov model
- Disease-modifying therapies for multiple sclerosis
- ▼Natalizumab for multiple sclerosis?
- Diagnosis and disease modifying treatments in multiple sclerosis
- Multiple sclerosis
- Problems with UK government's risk sharing scheme for assessing drugs for multiple sclerosis
- ▼Teriflunomide for multiple sclerosis